Cognitive and anxiety-depressive disorders in patients with age-related macular degeneration and cataracts

Abstract

Cognitive impairment and anxiety-depressive disorders in patients with age-related macular degeneration and cataract of old age are considered. 125 patients 60–74 years old suffering from age-related macular degeneration combined with cataract were examined at the Tambov branch of the interdisciplinary scientific and technical complex "Eye Microsurgery named after Academician S.N. Fedorov". 74 patients of similar age without age-related macular degeneration served as controls. Anxiety was assessed by the Spielberger – Hanin questionnaire, depressive status by the "Center for Epidemiological Studies — Depression scale". The validity of the differences was determined by the Mann – Whitney's U-criterion. It was established that among elderly patients suffering from age-related macular degeneration combined with cataract, cognitive deficits, an average level of personal anxiety, a significant specific gravity with an average level and an increased level of personal anxiety, depressive disorders, and in the control group — a low level of anxiety and the absence of generally depressive disorders. Therefore, age-related macular degeneration increases the incidence of cognitive and anxiety-depressive impairment, and patients suffering from this ophthalmic pathology need geriatric examination and correction of cognitive and anxiety-depressive impairment. In general, macular degeneration is the leading cause of vision loss in old age and can contribute to the development of cognitive and anxiety-depressive disorders, which are practically unexplored among this contingent.

Keywords

age macular degeneration / cataract / elderly people / cognitive impairment / anxiety-depressive disorders / geriatrics / ophthalmological diseases / geriatric syndromes

References

[1] Vorobyova IV. Monitoring of individual pathogenetically significant biochemical markers in lacrimal fluid, ophthalmological parameters in the combined pathology of diabetic retinopathy and age-related macular degeneration against the background of angioprotective and antioxidant therapy. Oftal'mologiya. 2018;15(2):189–199. (In Russ.).

[2] Воробьева И.В. Мониторинг отдельных патогенетически значимых биохимических маркеров в слезной жидкости, офтальмологических показателей при сочетанной патологии диабетической ретинопатии и возрастной макулярной дегенерации на фоне ангиопротекторной и антиоксидантной терапии // Офтальмология. 2018. Т. 15, № 2. С. 189–199.

[3] Polunina EG, Makarov IA, Makarova EYu, Angelova DV. Modern possibilities of preventing the occurrence and progression of cataracts. Oftal'mologiya. 2017;14(2):120–124. (In Russ.).

[4] Полунина Е.Г., Макаров И.А., Макарова Е.Ю., Анджелова Д.В. Современные возможности профилактики возникновения и прогрессирования катаракты // Офтальмология. 2017. Т. 14, № 2. С. 120–124.

[5] Daien V, Le Pape A, Heve D. Incidence, Risk Factors, and Impact of Age on Retinal Detachment after Cataract Surgery in France: A National Population Study. Ophthalmology. 2015;122(11):2179–2185.

[6] Daien V., Le Pape A., Heve D. Incidence, Risk Factors, and Impact of Age on Retinal Detachment after Cataract Surgery in France: A National Population Study // Ophthalmology. 2015. Vol. 122. No. 11. P. 2179–2185.

[7] Ermilov VV, Nesterova AA, Makhonina OV. Pathological correlations between Alzheimer's disease and age-related macular degeneration. Vestnik medicinskih tekhnologij. 2013;1:12–14. (In Russ.).

[8] Ермилов В.В., Нестерова А.А., Махонина О.В. Патологические корреляции между болезнью Альцгеймера и возрастной макулярной дегенерацией // Вестник медицинских технологий. 2013. № 1. С. 12–14.

[9] Richard AA. Alzheimer’s Disease and the Eye. J. Ophthalomogy. 2009;2:103–111.

[10] Richard A.A. Alzheimer’s Disease and the Eye // J. Ophthalomogy. 2009. Vol. 2. P. 103–111.

[11] Bibikov MM, Surkova VK. The problem of providing palliative care to patients with severe ophthalmopathology. Vse novosti oftal'mologii. 2012:1–5. (In Russ.).

[12] Бибков М.М., Суркова В.К. Проблема оказания паллиативной помощи пациентам с тяжелой офтальмопатологией // Все новости офтальмологии. 2012. С. 1–5.

[13] Jordanova N, Ristova J, Loleska S. Depression in ophthalmological patients. Prilozi. 2014;35(2):53–58.

[14] Jordanova N., Ristova J., Loleska S. Depression in ophthalmological patients // Prilozi. 2014. Vol. 35. No. 2. Р. 53–58.

[15] Balunov OA, Lukina LV, Semenova NV, Sitnik LI. Sovershenstvovanie poliprofessional'noj modeli okazaniya lechebno-diagnosticheskoj pomoshchi pri pogranichnyh psihicheskih rasstrojstvah u bol'nyh s organicheskimi zabolevaniyami golovnogo mozga. Saint-Petersburg: Federal'noe gosudarstvennoe byudzhetnoe uchrezhdenie "Nacional'nyj medicinskij issledovatel'skij centr psihiatrii i nevrologii imeni V.M. Bekhtereva" Ministerstva zdravoohraneniya Rossijskoj Federacii; 2012. (In Russ.).

[16] Балунов О.А., Лукина Л.В., Семенова Н.В., Ситник Л.И. Совершенствование полипрофессиональной модели оказания лечебно-диагностической помощи при пограничных психических расстройствах у больных с органическими заболеваниями головного мозга. СПб: Федеральное государственное бюджетное учреждение «Национальный медицинский исследовательский центр психиатрии и неврологии имени В.М. Бехтерева» Министерства здравоохранения Российской Федерации, 2012.

[17] Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research. 1975;12(3):189–198.

[18] Folstein M.F., Folstein S.E., McHugh P.R. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician // Journal of Psychiatric Research. 1975. Vol. 12. No. 3. P. 189–198.

[19] Khanin YuL. Research on anxiety in sports. Voprosy psihologii. 1978;6:92–99. (In Russ.).

[20] Ханин Ю.Л. Исследование тревоги в спорте // Вопросы психологии. 1978. № 6. С. 92–99.

[21] Andryushchenko AV, Drobizhev MYu, Dobrovolsky AV. Comparative evaluation of the CES-D, BDI and HADS(D) scale in the diagnosis of depression in General medical practice. Zhurnal nevrologii i psihiatrii im. S.S. Korsakova. 2003;5:11–18. (In Russ.).

[22] Андрющенко А.В., Дробижев М.Ю., Добровольский А.В. Сравнительная оценка шкал CES-D, BDI и HADS(D) в диагностике депрессий в общемедицинской практике // Журнал неврологии и психиатрии им. С.С. Корсакова. 2003. № 5. С. 11–18.

[23] Luca M, Luca A, Calandra C. Accelerated aging in major depression: the role of nitro-oxidative stress. Oxid. Med. Cell. Longev. 2013;11:230–236.

[24] Luca M., Luca A., Calandra C. Accelerated aging in major depression: the role of nitro-oxidative stress // Oxid. Med. Cell. Longev. 2013. Vol. 11. P. 230–236.

[25] Lai SW, Lin CL, Liao KF. Increased risk of Parkinson’s disease in cataracta patients: a population – based cohort study. Parkinsonism Relat Disord. 2015;21(1):68–71.

[26] Lai S.W., Lin C.L., Liao K.F. Increased risk of Parkinson’s disease in cataracta patients: a population – based cohort study // Parkinsonism Relat Disord. 2015. Vol. 21. No. 1. P. 68–71.

[27] Hawkins BS, Miskala PH, Bass EB, Bressler NM. Surgical removal vs observation for subfoveal choroidal neovascularization, either associated with the ocular histoplasmosis syndrome or idiopathic: II. Quality-of-life findings from a randomized clinical trial: SST Group H Trial: SST Report No. 10. Arch Ophthalmol. 2004;122(11):1616–1628.

[28] Hawkins B.S., Miskala P.H., Bass E.B., Bressler N.M. Surgical removal vs observation for subfoveal choroidal neovascularization, either associated with the ocular histoplasmosis syndrome or idiopathic: II. Quality-of-life findings from a randomized clinical trial: SST Group H Trial: SST Report No. 10 // Arch Ophthalmol. 2004. Vol. 122. No. 11. P. 1616–1628.

[29] Brody BL, Gamst AC, Williams RA. Depression, visual acuity, comorbidity, and disability associated with agerelated macular degeneration. Ophthalmology. 2001;108:1893–1901.

[30] Brody B.L., Gamst A.C., Williams R.A. Depression, visual acuity, comorbidity, and disability associated with agerelated macular degeneration // Ophthalmology. 2001. Vol. 108. P. 1893–1901.

[31] Singer M. Advancesin the management of macular degeneration. F1000 Prime Reports. 2014;10:141–147.

[32] Singer M. Advancesin the management of macular degeneration // F1000 Prime Reports. 2014. Vol. 10. P. 141–147.

[33] Milyutkina SO, Kovalevskaya TI. Functional disorders of the macular region of the retina as a factor in the development of the socio-psychological area of maladjustment in patients with age-related macular degeneration. Aktual'nye voprosy psihiatrii, narkologii i medicinskoj psihologii. 2014;17(1):128–136. (In Russ.).

[34] Милюткина С.О., Ковалевская Т.И. Функциональные нарушения макулярной области сетчатки как фактор развития социально-психологической области дезадантации у больных возрастной макулярной дегенерацией // Актуальные вопросы психиатрии, наркологии и медицинской психологии. 2014. Т. 17, № 1. С. 128–136.

RIGHTS & PERMISSIONS

Agarkov N.M., Yablokov M.M., Konyaev D.A., Popova N.V.